DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr. Reddy's Laboratories Limited
02 1Wavelength Enterprises Ltd
03 2Wavelength Enterprises Ltd.
04 1IOL Chemicals and Pharmaceuticals Ltd.
05 2Moehs BCN SL
06 1Teva API India Private Ltd
07 1Amoli Organics (A Division of Umedica Laboratories Pvt.Ltd)
08 1Aurobindo Pharma Limited
09 2Biocon Limited
10 1Chromo Laboratories India Private Limited
11 2F.I.S. - Fabbrica Italiana Sintetici S.p.A.
12 1F.I.S. FABBRICA ITALIANA SINTETICI S.P.A.
13 3Glenmark Life Sciences Limited
14 2HIKAL LIMITED
15 2Harman Finochem Limited
16 2Honour Lab Limited
17 1Jubilant Pharmova Limited
18 1Lee Pharma Ltd.
19 3MSN Life Sciences Private Limited
20 3MSN Pharmachem Private Limited
21 1MYLAN LABORATORIES LIMITED
22 1Optimus Drugs Private Limited
23 1PURE AND CURE HEALTHCARE PRIVATE LIMITED
24 1SMS Pharmaceuticals Limited
25 1Tianish Laboratories Private Limited
26 1Union Quimico Farmaceutica SA
27 2Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd.
28 1zhejiang jiuzhou pharmaceutical Co., Ltd.
01 1SITAGLIPTIN ANHYDR0US
02 1SITAGLIPTIN HYDROCHLORIDE MONOHYDRATE
03 9SITAGLIPTIN PHOSPHATE
04 1SITAGLIPTIN PHOSPHATE ANHYDRATE
05 1SITAGLIPTIN PHOSPHATE MONOHYDRATE
06 1Sitagliptin
07 1Sitagliptin Base
08 1Sitagliptin Hydrochloride
09 11Sitagliptin Phosphate
10 4Sitagliptin Phosphate Anhydrous
11 5Sitagliptin Phosphate Monohydrate
12 1Sitagliptin phosphate
13 1Sitagliptin phosphate monohydrate
14 1sitagliptin phosphate
15 1sitagliptin phosphate anhydrous
16 2sitagliptin phosphate monohydrate
01 3China
02 3France
03 27India
04 1Israel
05 3Italy
06 3Spain
07 1U.S.A
08 1Blank
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 71796-035
Start Marketing Date : 2021-02-19
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
NDC Package Code : 58175-0620
Start Marketing Date : 2019-04-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
IOL Chemicals is an innovation-driven bulk drug, Intermediate and Specialty Chemicals company.
NDC Package Code : 49716-338
Start Marketing Date : 2023-10-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Moehs Group, a reference company in the production of pharmaceutical active ingredients.
NDC Package Code : 71495-0002
Start Marketing Date : 2019-01-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
TAPI offers customized CDMO Solutions for API development and manufacturing services.
NDC Package Code : 15894-0018
Start Marketing Date : 2015-12-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
NDC Package Code : 58175-0638
Start Marketing Date : 2020-09-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
NDC Package Code : 58175-0636
Start Marketing Date : 2020-09-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Moehs Group, a reference company in the production of pharmaceutical active ingredients.
NDC Package Code : 71495-0004
Start Marketing Date : 2023-09-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12666-0013
Start Marketing Date : 2010-05-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
SITAGLIPTIN PHOSPHATE ANHYDROUS
NDC Package Code : 12666-0015
Start Marketing Date : 2012-08-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Janumet manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Janumet, including repackagers and relabelers. The FDA regulates Janumet manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Janumet API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Janumet manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Janumet supplier is an individual or a company that provides Janumet active pharmaceutical ingredient (API) or Janumet finished formulations upon request. The Janumet suppliers may include Janumet API manufacturers, exporters, distributors and traders.
click here to find a list of Janumet suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Janumet as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Janumet API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Janumet as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Janumet and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Janumet NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Janumet suppliers with NDC on PharmaCompass.
We have 24 companies offering Janumet
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
